Corrigendum to "Epigenetic activation of human kallikrein 13 enhances malignancy of lung adenocarcinoma by promoting N-cadherin expression and laminin degradation" [Biochem. Biophys. Res. Commun. 409 (2011) 442-447]

Corresponding authors at: Center for Molecular Medicine, China MedicalUniversity Hospital, No. 6 Hsueh-Shih Road, Taichung 40447, Taiwan. Fax: +886 422333496 (R.-H. Chou); National Institute of Cancer Research, National HealthResearch Institutes, No. 35 Keyan Road, Zhunan Town, Miaoli 35053, Taiwan. Fax:+886 37 586463 (W.-S.W. Chang).E-mail addresses: rhchou@gmail.com (R.-H. Chou), wayne@nhri.org.tw(W.-S.W. Chang).